Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

CUSIP: 23285D109

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
127,940,509
Total 13F shares
74,960,438
Share change
-2,620,205
Total reported value
$415,264,156
Put/Call ratio
0%
Price per share
$5.54
Number of holders
134
Value change
-$14,542,700
Number of buys
84
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 23285D109?
CUSIP 23285D109 identifies CTKB - Cytek Biosciences, Inc. - Common Stock - $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) as of Q3 2024

As of 30 Sep 2024, Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,960,438 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, HHLR ADVISORS, LTD., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NEW YORK STATE COMMON RETIREMENT FUND, WELLINGTON MANAGEMENT GROUP LLP, DIMENSIONAL FUND ADVISORS LP, and NORTHERN TRUST CORP. This page lists 134 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.